Abstract:Background: Pig erythrocytes are potentially useful to solve the worldwide shortage of human blood for transfusion. Domestic pig erythrocytes, however, express antigens that are bound by human preformed antibodies. Advances in genetic engineering have made it possible to rapidly knock out the genes of multiple xenoantigens, namely galactose α1,3 galactose (aGal) and N-glycolylneuraminic acid (Neu5Gc). We have recently targeted the GGTA1 and CMAH genes with zinc finger endonucleases resulting in double knockout pigs that no longer express aGal or Neu5Gc and attract significantly fewer human antibodies. In this study, we characterized erythrocytes from domestic and genetically modified pigs, baboons, chimpanzees, and humans for binding of human and baboon natural antibody, and complement-mediated lysis. Methods: Distribution of anti-Neu5Gc IgG and IgM in pooled human AB serum was analyzed by ELISA. Erythrocytes from domestic pigs (Dom), aGal knockout pigs (GGTA1 KO), aGal and Neu5Gc double knockout pigs (GGTA1/CMAH KO), baboons, chimpanzees, and humans were analyzed by flow cytometry for aGal and Neu5Gc expression. In vitro comparative analysis of erythrocytes was conducted with pooled human AB serum and baboon serum. Total antibody binding was accessed by hemagglutination; complement-dependent lysis was measured by hemolytic assay; IgG or IgM binding to erythrocytes was characterized by flow cytometry. Results: The pooled human AB serum contained 0.38 μg/ml anti-Neu5Gc IgG and 0.085 μg/ml anti-Neu5Gc IgM. Both Gal and Neu5Gc were not detectable on GGTA1/CMAH KO erythrocytes. Hemagglutination of GGTA1/CMAH KO erythrocytes with human serum was 3.5-fold lower compared with GGTA1 KO erythrocytes, but 1.6-fold greater when agglutinated with baboon serum. Hemolysis of GGTA1/CMAH KO erythrocytes by human serum (25%) was reduced 9-fold compared with GGTA1 KO erythrocytes, but increased 1.64-fold by baboon serum. Human IgG binding was reduced 27-fold on GGTA1/CMAH KO erythrocytes compared with GGTA1 KO erythrocytes, but markedly increased 3-fold by baboon serum IgG. Human IgM binding was decreased 227-fold on GGTA1/CMAH KO erythrocytes compared with GGTA1 KO erythrocytes, but enhanced 5-fold by baboon serum IgM. Conclusions: Removal of aGal and Neu5Gc antigens from pig erythrocytes significantly reduced human preformed antibody-mediated cytotoxicity but may have complicated future in vivo analysis by enhancing reactivity from baboons. The creation of the GGTA1/CMAH KO pig has provided the xenotransplantation researcher with organs and cells that attract fewer human antibodies than baboon and our closest primate relative, chimpanzee. These finding suggest that while GGTA1/CMAH KO erythrocytes may be useful for human transfusions, in vivo testing in the baboon may not provide a direct transplantation to the clinic.

Pig‐a gene mutation database

The PIG-A gene mutation assay in human biomonitoring and disease

Development of a Novel PIG-A Gene Mutation Assay Based on a GPI-anchored Fluorescent Protein Sensor

The in Vivo Pig-a Gene Mutation Assay is Applied to Study the Genotoxicity of Procarbazine Hydrochloride in Sprague-Dawley Rats

Recgip, A Database of Reproduction Candidate Genes in Pigs Based on Bibliomics

Assessment of Pig-a, Micronucleus and Comet Assay Endpoints in Tg.RasH2 Mice Carcinogenicity Study of Aristolochic Acid I.

A Population Study Using The Human Erythrocyte Pig-A Assay

A Compendium of Genetic Regulatory Effects Across Pig Tissues

Molecular Cloning and Expression Analysis of the GNAS Gene in Pig and Porcine Fibroblast Cells.

Assessment of the In Vitro Phosphatidylinositol Glycan Class A (PIG-A) Gene Mutation Assay Using Human TK6 and Mouse Hepa1c1c7 Cell Lines

PBmice: an Integrated Database System of Piggybac (PB) Insertional Mutations and Their Characterizations in Mice.

Expression profile and functional analysis of the testis-specific gene,PigM,in mice

PIG‐A Gene Mutation As a Genotoxicity Biomarker in Human Population Studies: an Investigation in Lead‐exposed Workers

ETph: Enhancers and Their Targets in Pig and Human Database.

PIG-A gene mutation as a mutagenicity biomarker among coke oven workers

The Potential Application of Human PIG‐A Assay on Azathioprine‐treated Inflammatory Bowel Disease Patients

Application of the in Vivo Pig-a Gene Mutation Assay to Test the Potential Genotoxicity of P-Phenylenediamine.

N-linked glycan profiling of GGTA1/CMAH knockout pigs identifies new potential carbohydrate xenoantigens

Development of a database system for mapping insertional mutations onto the mouse genome with large-scale experimental data

Erythrocytes from GGTA1/CMAH knockout pigs: implications for xenotransfusion and testing in non-human primates

Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes